Immunohistochemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas

10Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Mounting evidence indicates that alteration of apoptosis is involved in the mechanisms of cancer development. PUMA, a pro-apoptotic member of Bcl-2 family, mediates p53-dependent and -independent apoptosis. Aim: The aim of this study was to explore whether alteration of PUMA protein expression is a characteristic of human gastric carcinomas. Patients and methods: We analysed expression of PUMA protein in 60 gastric adenocarcinomas by immunohistochemistry. Also, we examined PUMA gene mutation in the same tissues by a single-strand conformation polymorphism. Results: PUMA protein expression was detected in 44 cases (73%) of the 60 gastric carcinomas, whereas it was not detected in normal gastric mucosal epithelial cells. The mutational analysis revealed no PUMA mutation in the gastric carcinomas. Conclusions: Our data suggest that PUMA mutation is not a direct target of inactivation in gastric tumourigenesis. Also, increased expression of PUMA in malignant gastric epithelial cells compared with normal mucosal epithelial cells suggested that PUMA expression may play a role in gastric tumourigenesis. © 2006 Editrice Gastroenterologica Italiana S.r.l.

Cite

CITATION STYLE

APA

Yoo, N. J., Lee, J. W., Jeong, E. G., & Lee, S. H. (2007). Immunohistochemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas. Digestive and Liver Disease, 39(3), 222–227. https://doi.org/10.1016/j.dld.2006.11.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free